Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$435K Sell
26,761
-9,386
-26% -$167K ﹤0.01% 732
2026
Q1
$688K Hold
36,147
﹤0.01% 679
2025
Q4
$592K Sell
36,147
-24,269
-40% -$427K ﹤0.01% 716
2025
Q3
$1.18M Buy
60,416
+30,208
+100% +$542K ﹤0.01% 1296
2025
Q2
$610K Hold
30,208
﹤0.01% 1439
2025
Q1
$415K Sell
30,208
-9,857
-25% -$136K ﹤0.01% 1497
2024
Q4
$475K Buy
40,065
+10,326
+35% +$163K ﹤0.01% 1454
2024
Q3
$534K Buy
+29,739
New +$542K ﹤0.01% 1468

Other funds holding XP

Macquarie Group's XP Position: Q2 2026 in Review

Macquarie Group reduced its XP (XP) stake by 26% in Q2 2026, selling an estimated $167K and leaving 26,761 shares worth $435K. The position accounts for ﹤0.01% of the portfolio, ranked #732.

Macquarie Group first reported a position in XP in Q3 2024 and has held it in 8 quarters since. The position peaked at $1.18M in Q3 2025. 320 funds tracked by Wall St. Rank hold XP as of Q2 2026.

  • Macquarie Group held 26,761 shares of XP worth $435K as of Q2 2026.
  • Macquarie Group sold 9,386 XP shares in Q2 2026, an estimated $167K.
  • XP made up ﹤0.01% of Macquarie Group's portfolio in Q2 2026, its #732 holding.
  • Macquarie Group first reported a position in XP in Q3 2024 and has held it in 8 quarters since.
  • Macquarie Group's XP position peaked at $1.18M in Q3 2025.
  • 320 funds tracked by Wall St. Rank held XP as of Q2 2026.

Based on Macquarie Group's 13F filing for Q2 2026, filed 14 Aug 2026.